Memorial Sloan-Kettering Cancer Center-Site Number:8400002

New York, New York 10021

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed